Profile
David Baram was the founder of SmartZyme Biopharma, Inc., founded in 2014, where the title held was Chief Technology Officer from 2014 to 2017.
Dr. Baram is also the founder of Cellergy Therapeutics Ltd.,MyBiotics Pharma Ltd...
Dr. Baram currently holds the position of President, Chief Executive Officer & Director at Emendo Biotherapeutics, Inc., starting in 2015.
Dr. Baram completed graduate and doctorate degrees at the Weizmann Institute of Science.
David Baram active positions
| Companies | Position | Start |
|---|---|---|
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Chief Executive Officer | 31/12/2014 |
Former positions of David Baram
| Companies | Position | End |
|---|---|---|
SmartZyme Biopharma, Inc.
SmartZyme Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides platform for protein design and engineering of both new and better therapeutics | Founder | 30/09/2017 |
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that discovers and develops microbiome-based products aimed at restoring microbial equilibrium for the biopharmaceutical | Founder | - |
Training of David Baram
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SmartZyme Biopharma, Inc.
SmartZyme Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides platform for protein design and engineering of both new and better therapeutics | Commercial Services |
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that discovers and develops microbiome-based products aimed at restoring microbial equilibrium for the biopharmaceutical | Health Technology |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
- Stock Market
- Insiders
- David Baram
















